About 115,000 results
Open links in new tab
  1.  

  2. pfizer alopecia treatment

    Organizing and summarizing search results for you
    Pfizer has developed drugs to help stimulate hair growth in people who have alopecia areata and other autoimmune hair loss conditions. Ritlecitinib is a Pfizer alopecia drug that was given Breakthrough Therapy status by the FDA in 2018. LITFULO is another Pfizer drug that has been approved by the FDA and the European Medicines Agency (EMA) for the treatment of alopecia areata. LITFULO is an oral pill that is prescribed to be taken once a day.
    wimpoleclinic.com+3
    4 Sources
    Pfizer Alopecia Treatment: What Is Ritlecitinib & How Does It Work?
    Ritlecitinib is a drug designed to help stimulate hair growth in people who have alopecia areata and other autoimmune hair loss conditions. Back in 2018, this Pfizer alopecia drug …
    Wimpole Clinic
    https://wimpoleclinic.com/blog/pfizer-alopecia-treatment-what-is-ritlecitinib-how-does-it-work/
    New drug to restore hair loss in alopecia patients
    The US Food and Drug Administration (FDA) has approved the new medicine, LITFULO, Pfizer announced last week. The drug has been developed in the form of an oral pill that is prescr…
    Interesting Engineering
    https://interestingengineering.com/science/litfulo-ritlecitinib-new-drug-for-hair-loss-in-alopecia-patients
    3
    4
    +2 more
    34
    Pfizer Receives Breakthrough Therapy Designation from FDA for PF ...
    NEW YORK-- (BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced its investigational oral Janus kinase 3 (JAK3) inhibitor PF-06651600 received Breakthrough Therapy designation fr…
    Pfizer
    https://www.pfizer.com/news/press-release/press-release-detail/pfizer_receives_breakthrough_therapy_designation_from_fda_for_pf_06651600_an_oral_jak3_inhibitor_for_the_treatment_of_patients_with_alopecia_areata
    Pfizer Receives Positive CHMP Opinion for Alopecia Areata Treatment
    New York, July 21, 2023 — Pfizer Inc. (NYSE: PFE) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a po…
    Pfizer
    https://www.pfizer.com/news/announcements/pfizer-receives-positive-chmp-opinion-alopecia-areata-treatment
     
  3. Pfizer
    https://www.pfizer.com › news › press-release › press...

    FDA Approves Pfizer’s LITFULO™ (Ritlecitinib) for Adults and ...

     
  4. Reuters
    https://www.reuters.com › business › healt…

    US FDA approves Pfizer's hair loss drug | Reuters

    Jun 23, 2023 · The U.S. Food and Drug Administration has approved Pfizer Inc's drug to treat hair loss caused by an autoimmune disease, the company said on Friday.